X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.biospace.com/article/gilead-wins-hiv-patent-suit-nabs-oncology-and-inflammation-startup/?s=79
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-delstrigo-doravirine-lamivudine-and-tenofovir-disoproxil-fumarate-27898.pdf
https://www.fiercepharma.com/pharma/gilead-cant-escape-antitrust-suit-centered-pay-delay-deal-cipla-judge-says
https://www.fiercebiotech.com/biotech/antios-therapy-could-be-bridge-hep-b-treatment-first-fda-hold-resolve
https://www.prnewswire.com/news-releases/antios-therapeutics-ati-2173-demonstrates-suppression-of-hepatitis-b-virus-in-phase-2a-study-ati-1428-and-ati-1645-exhibit-potent-antiviral-activity-in-a-nonclinical-study-301574996.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201806
https://www.fiercepharma.com/pharma/gilead-merck-and-others-slapped-pay-for-delay-lawsuits-over-lucrative-hiv-and-cholesterol
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204287
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204287
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204131
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208740
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208740
https://www.business-standard.com/article/news-cm/strides-receives-usfda-approval-for-emtricitabine-and-tenofovir-disoproxil-fumarate-tablets-121011500225_1.html
https://www.newswise.com/articles/common-hiv-drugs-increase-a-type-of-immunity-in-the-gut
http://www.pharmatimes.com/news/viiv_hiv_prevention_trial_stopped_early_on_efficacy_1340441
https://www.raps.org/news-and-articles/news-articles/2020/1/gilead-claims-truvada-patents-in-hhs-complaint-ar
https://www.fiercepharma.com/marketing/facebook-takes-down-misleading-hiv-ads-after-letter-from-lgbtq-groups-media-coverage-and
https://www.fiercepharma.com/marketing/gilead-s-converting-truvada-prep-users-to-descovy-faster-than-expected-analyst
http://www.pharmatimes.com/news/vemlidy_tackles_hep_b_in_late-stage_trials_1316991
https://www.biospace.com/article/merck-s-pifeltro-and-delstrigo-approved-in-hiv-patients-whose-disease-is-under-control/
https://www.biospace.com/article/fda-action-alert-merck-and-amarin/
https://www.biospace.com/article/gilead-and-lyndra-team-to-develop-long-acting-hiv-therapies/
https://www.raps.org/news-and-articles/news-articles/2019/7/fda-eliminates-rems-for-hiv-drug-truvada-and-its-g?feed=Regulatory-Focus
https://www.raps.org/news-and-articles/news-articles/2019/6/fda-plots-shift-away-from-csr-pilot-to-forge-new-t
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206894
https://www.ibtimes.com/hiv-drug-truvada-costs-2000-us-only-8-australia-2792684
https://www.in-pharmatechnologist.com/Article/2019/05/14/CDC-receives-Truvada-donation-as-generic-competition-increases
https://www.fiercepharma.com/pharma/gilead-fails-to-convince-judge-to-toss-hiv-drug-case
https://www.biospace.com/article/yale-researchers-discover-protein-in-the-immune-system-can-help-suppress-hiv/
https://www.pharmacompass.com/pdf/news/truvada-emtricitabine-tenofovir-disoproxil-fumarate-gilead-vs-zydus-1547795301.pdf
https://www.ema.europa.eu/documents/overview/delstrigo-epar-medicine-overview_en.pdf
https://www.fiercepharma.com/pharma/doj-tells-supreme-court-it-has-lost-interest-its-gilead-whistleblower-case
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206569
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206569
https://health.economictimes.indiatimes.com/news/pharma/south-africas-aspen-launches-three-in-one-hiv-drug/66821480
https://www.prnewswire.com/news-releases/hilliard-martinez-gonzales-llp-gilead-sued-for-intentionally-withholding-safer-hiv-drug-300752539.html
https://www.thehindubusinessline.com/companies/laurus-labs-transfers-new-drug-application-to-casi-pharma/article25300815.ece
http://www.pharmatimes.com/news/chmp_puts_13_therapies_forward_for_eu_approval_1253165
http://www.pharmatimes.com/news/viiv_submits_two-drug_regimen_for_hiv_in_europe_1252248
https://www.reuters.com/article/us-merck-co-fda/fda-approves-two-new-hiv-drugs-from-merck-idUSKCN1LF2IL
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209721
https://extranet.who.int/prequal/news/newly-prequalified-active-pharmaceutical-ingredient-api-20
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206481
https://www.prnewswire.com/news-releases/contravir-pharmaceuticals-to-present-at-virtual-investor-conference-300676434.html
Market Place
Share 
